Haas M, McBrayer D G, Yankaskas J R
Department of Pathology, University of Chicago, Illinois 60637.
Am J Physiol. 1993 Jan;264(1 Pt 1):C189-200. doi: 10.1152/ajpcell.1993.264.1.C189.
To investigate cellular mechanisms involved in the regulation of basolateral Na-K-Cl cotransport in airway epithelia, we determined saturable basolateral [3H]bumetanide binding, a measure of functioning cotransporters, in primary cultures of canine tracheal and human nasal epithelial cells, including cells from patients with cystic fibrosis (CF). As we previously reported [M. Haas, L. G. Johnson, and R. C. Boucher. Am. J. Physiol. 259 (Cell Physiol. 28): C557-C569, 1990], isoproterenol and hypertonic cell shrinkage produce an equivalent stimulation of [3H]bumetanide binding to dog tracheal cells. We now find that apical ATP and UTP, which stimulate apical Cl channels and Cl secretion in normal and CF airway cells by an adenosine 3',5'-cyclic monophosphate (cAMP)-independent mechanism (S. J. Mason, A. M. Paradiso, and R. C. Boucher. Br. J. Pharmacol. 103: 1649-1656, 1991), increase basolateral [3H]bumetanide binding to dog tracheal cells to the same extent as do isoproterenol and hypertonic shrinkage. The stimulatory effects of ATP and UTP on binding are inhibited by apical addition of a Cl channel blocker, the indanyloxyacetic acid derivative IAA-94 (0.2 mM), or by raising basolateral K concentration ([K]b) from 3.3 to 40 mM, suggesting these effects are secondary to apical Cl efflux via channels. Apical IAA-94 and increased [K]b also inhibit stimulation of binding by isoproterenol by approximately 50%, suggesting that part (but not all) of the effect of the beta-agonist on basolateral cotransport is secondary to apical Cl efflux, with an additional component of direct stimulation of cotransport via cAMP. In support of this interpretation, we find that isoproterenol and a membrane-permeable cAMP analogue increase [3H]bumetanide binding to primary cultures of CF nasal epithelial cells, in which significant cAMP-mediated stimulation of apical Cl efflux does not occur. [3H]bumetanide binding to CF nasal cells is also stimulated by apical ATP, and levels of saturable [3H]bumetanide binding to CF cells are 1.3-1.5 times those in non-CF nasal cells under both basal and stimulated conditions. The results suggest that basolateral Na-K-Cl cotransport in airway cells may be upregulated in two distinct ways: 1) directly via a cAMP-dependent cascade, and 2) as a secondary response to apical Cl channel activation. Both of these mechanisms appear to be intact in CF.
为了研究气道上皮细胞基底外侧钠 - 钾 - 氯共转运调节所涉及的细胞机制,我们测定了犬气管和人鼻上皮细胞原代培养物中可饱和的基底外侧[³H]布美他尼结合情况,这是一种衡量共转运体功能的指标,其中包括来自囊性纤维化(CF)患者的细胞。正如我们之前报道的[M. 哈斯,L. G. 约翰逊,以及R. C. 鲍彻。《美国生理学杂志》259(细胞生理学28):C557 - C569,1990],异丙肾上腺素和高渗性细胞皱缩对犬气管细胞的[³H]布美他尼结合产生同等程度的刺激。我们现在发现,顶端ATP和UTP,它们通过一种不依赖于3',5'-环磷酸腺苷(cAMP)的机制刺激正常和CF气道细胞中的顶端Cl⁻通道和Cl⁻分泌(S. J. 梅森,A. M. 帕拉迪索,以及R. C. 鲍彻。《英国药理学杂志》103:1649 - 1656,1991),与异丙肾上腺素和高渗皱缩一样,能使犬气管细胞基底外侧的[³H]布美他尼结合增加到相同程度。ATP和UTP对结合的刺激作用可被顶端添加Cl⁻通道阻滞剂、茚满氧基乙酸衍生物IAA - 94(0.2 mM),或通过将基底外侧K⁺浓度([K⁺]b)从3.3 mM提高到40 mM所抑制,这表明这些作用是顶端Cl⁻通过通道外流的继发效应。顶端IAA - 94和升高的[K⁺]b也能将异丙肾上腺素对结合的刺激作用抑制约50%,这表明β - 激动剂对基底外侧共转运的部分(但不是全部)作用是顶端Cl⁻外流的继发效应,还有通过cAMP直接刺激共转运的额外成分。支持这一解释的是,我们发现异丙肾上腺素和一种可透过膜的cAMP类似物能增加[³H]布美他尼与CF鼻上皮细胞原代培养物的结合,在CF鼻上皮细胞中不会发生显著的cAMP介导的顶端Cl⁻外流刺激。顶端ATP也能刺激CF鼻细胞的[³H]布美他尼结合,并且在基础和刺激条件下,CF细胞中可饱和的[³H]布美他尼结合水平是非CF鼻细胞的1.3 - 1.5倍。结果表明,气道细胞中的基底外侧钠 - 钾 - 氯共转运可能通过两种不同方式上调:1)直接通过cAMP依赖性级联反应,以及2)作为对顶端Cl⁻通道激活的继发反应。这两种机制在CF中似乎都是完整的。